Neuraly
Business Services · Maryland, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
704 Quince Orchard Rd Ste 320, Gaithersb...Phone Number
(301) 658-6100Website
www.neuralymed.comRevenue
$12.2 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
1
1
1
1
About Neuraly
Neuraly is a clinical stage biotechnology company focused on discovering and developing revolutionary treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. The company aims to create new drugs that target innovative pathways to provide effective therapies for progressive diseases. With a dedicated team of professionals, Neuraly is committed to improving the lives of patients suffering from severe neurodegenerative conditions. Their clinical development strategy emphasizes the inhibition of pathological glial activation to prevent neuronal cell death.Explore more
Neuraly Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neuraly your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Neuraly, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Neuraly
Check if Neuraly has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Neuraly recently announced quarterly report
Funding: Get notified immidiatlly once Neuraly has new funding data
Website visits: Recent activity has been detected on your website
Check out if Neuraly is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Neuraly launches new products
Click to see if Neuraly had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Neuraly
Find more new buyers
Compare Similar Companies to Neuraly
Compare insights from companies similar to Neuraly, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Neuraly
$12.2M
51-200
Private
<$5M
2016
SS
Svetlana SosnovtsevaExecutive Director, Bioanalytical Development
Company Profile Activity
Activity Insights
Neuraly is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Neuraly is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Neuraly.
Neuraly financials insights
Gather financial insights about Neuraly, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Neuraly Tech Stack
A closer look at the technologies used by Neuraly
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Product Development, Research & Development, Clinical Systems
Funding
Neuraly has received an SBA PPP loan for $350,000-1 million from Bank of America.
Funding
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Neuraly
Sign Up For FreeTo access detailed company insights
Neuraly is a clinical stage biotechnology company focused on discovering and developing revolutionary treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. The company aims to create new drugs that target innovative pathways to provide effective therapies for progressive diseases. With a dedicated team of professionals, Neu... Read More
